Nonsurgical Rhinoplasty: Results from a Retrospective Study of Rino-4-Puntos Technique with Hyaluronic Acid

被引:0
|
作者
Silikovich, Fernando [1 ]
Kroumpouzos, George [2 ,3 ]
机构
[1] Concepto 4 Puntos Clin, Av Monroe 2270 1405, RA-B1428 Buenos Aires, Argentina
[2] Warren Alpert Med Sch Brown Univ, Dept Dermatol, Providence, RI 02912 USA
[3] GK Dermatol PC, 541 Main St,Suite 320, South Weymouth, MA 02190 USA
关键词
Rhinoplasty; Nose; Hyaluronic acid; Dermal fillers; Treatment efficacy; Patient satisfaction; Patient safety; FILLERS; ARTERY;
D O I
10.1007/s00266-024-04263-z
中图分类号
R61 [外科手术学];
学科分类号
摘要
BackgroundNonsurgical rhinoplasty (NSR) utilizing hyaluronic acid (HA) filler injections is increasingly used to address nose shape issues. While refinements have been proposed, the technique lacks standardization.ObjectivesOur study aimed to evaluate the aesthetic outcome, longevity of results, safety, and patient satisfaction with the novel Rino-4-Puntos (R4P) NSR technique.MethodsThis is a retrospective study of consecutive individuals treated with R4P between January 2021 and July 2023. All participants had one of the four indications: rectification of the dorsum (21%), triangulation of the tip (32%), projection (25%), and strengthening of the columella (22%). Each patient received two hyaluronic acid (HA) fillers: one with intermediate G prime (G ') at Points 1-3 and another with high G ' at Point 4, which is further divided into Points 4.1, 4.2, 4.3, and 4.4. The injection points were as follows: P1 (radix, 0.05-0.15 mL, supraperiosteal), P2 (supratip, 0.025 mL, suprachondrial), P3 (tip, 0.15 mL, deep fat), P4 (columella, 0.30 mL, supraperiosteal [4.1], or deep fat [4.2, 4.3, and 4.4]).ResultsFour hundred individuals (n = 284 [71%] females) are included. The mean filler volume used was 0.65 +/- 0.17 mL. Injecting small boluses (<= 0.05 mL) in the midline at deep planes minimized the risk of adverse effects, as no vascular complications occurred. Ninety-three percent of participants considered the overall outcome at least satisfactory ("good," "very good," or "excellent"). The treatment effect was maintained for a median of 11 months.ConclusionsThe R4P technique refines NSR by combining enhanced aesthetic outcome, longevity, and safety.Level of Evidence IVThis journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
引用
收藏
页码:672 / 682
页数:11
相关论文
共 50 条
  • [11] The Effectiveness of a New Topical Formulation Containing GSH-C4 and Hyaluronic Acid in Seborrheic Dermatitis: Preliminary Results of an Exploratory Pilot Study
    Campione, Elena
    Mazzilli, Sara
    Lanna, Caterina
    Cosio, Terenzio
    Palumbo, Vincenzo
    Cesaroni, Gaia
    Lozzi, Flavia
    Diluvio, Laura
    Bianchi, Luca
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2019, 12 : 881 - 885
  • [12] The effect of intra-articular hyaluronic acid on gait in older people with knee osteoarthritis: Preliminary results from a randomized, controlled study
    DeCaria, J. E.
    Petrella, R. J.
    Montero-Odasso, M. M.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2009, 57 : S169 - S169
  • [13] Comparison of Intra-articular Hyaluronic Acid and Platelet- Rich Plasma Injection in Knee Osteoarthritis: Do the Results Differ in Geriatric Patients? A Retrospective Observational Study
    Pamuk, Cagdas
    ANNALS OF GERIATRIC MEDICINE AND RESEARCH, 2022, 26 (04): : 340 - 346
  • [14] Mid-Face Volumization With Hyaluronic Acid: Injection Technique and Safety Aspects from a Controlled, Randomized, Double-Blind Clinical Study
    Prager, Welf
    Agsten, Karla
    Kravtsov, Maria
    Kerscher, Martina
    JOURNAL OF DRUGS IN DERMATOLOGY, 2017, 16 (04) : 351 - 357
  • [15] Relapsed actinic keratosis evaluation (RAKE) study: Preliminary results after 4 months of treatment with 3% diclofenac in 2.5% hyaluronic acid gel or cryotherapy
    Chimenti, Sergio
    Santoianni, P.
    Crocetta, Donatello
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (02) : AB152 - AB152
  • [16] Head and neck cancer patients under radiotherapy undergoing skin application of hydrogel dressing or hyaluronic acid: results from a prospective, randomized study
    Marion Perréard
    Natacha Heutte
    Bénédicte Clarisse
    Maxime Humbert
    Alexandra Leconte
    Bernard Géry
    Thomas Boisserie
    Nathalie Dadoun
    Laurent Martin
    David Blanchard
    Emmanuel Babin
    Vianney Bastit
    Supportive Care in Cancer, 2024, 32
  • [17] Hyaluronic acid is superior to collagen in the correction of moderate to severe nasolabial folds: Results from a randomized, blinded, controlled, multicenter effectiveness and safety study
    Narins, Rhoda
    Maas, Corey
    Jones, Derek
    Monheit, Gary
    Coleman, William, III
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 62 (03) : AB57 - AB57
  • [18] Safe and Effective Restoration of Jawline Definition With Hyaluronic Acid Injectable Gel VYC-25L: Results From a Randomized Controlled Study
    Rivkin, Alexander
    Green, Jeremy B.
    Bruce, Suzanne
    Cox, Sue Ellen
    Hevia, Oscar
    Chawla, Smita
    Sartor, Marta
    AESTHETIC SURGERY JOURNAL, 2024, 44 (12) : 1341 - 1349
  • [19] AUTOLOGOUS FAT TRANSPLANTATION HAS A LONG TERM EFFICACY ON SCLERODERMA SKIN FIBROSIS: RESULTS FROM A CONTROLLED STUDY VERSUS HYALURONIC ACID FILLER
    Del Papa, N.
    Sambataro, D.
    Zaccara, E.
    Maglione, W.
    Andracco, R.
    Caviggioli, F.
    Di Luca, G.
    Parafioriti, A.
    Vitali, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 822 - 822
  • [20] Head and neck cancer patients under radiotherapy undergoing skin application of hydrogel dressing or hyaluronic acid: results from a prospective, randomized study
    Perreard, Marion
    Heutte, Natacha
    Clarisse, Benedicte
    Humbert, Maxime
    Leconte, Alexandra
    Gery, Bernard
    Boisserie, Thomas
    Dadoun, Nathalie
    Martin, Laurent
    Blanchard, David
    Babin, Emmanuel
    Bastit, Vianney
    SUPPORTIVE CARE IN CANCER, 2024, 32 (01)